TARZIA, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 31.266
EU - Europa 26.701
AS - Asia 10.962
SA - Sud America 710
Continente sconosciuto - Info sul continente non disponibili 370
AF - Africa 143
OC - Oceania 38
AN - Antartide 1
Totale 70.191
Nazione #
US - Stati Uniti d'America 30.924
NL - Olanda 9.519
GB - Regno Unito 6.217
CN - Cina 5.744
SG - Singapore 2.854
UA - Ucraina 2.771
IT - Italia 1.851
SE - Svezia 1.654
TR - Turchia 1.133
DE - Germania 1.062
RU - Federazione Russa 944
FI - Finlandia 942
IE - Irlanda 598
FR - Francia 589
BR - Brasile 529
VN - Vietnam 407
CA - Canada 230
IN - India 195
JP - Giappone 136
BE - Belgio 114
PL - Polonia 106
HK - Hong Kong 86
BD - Bangladesh 85
EU - Europa 80
AR - Argentina 65
ES - Italia 65
AT - Austria 61
KR - Corea 57
MX - Messico 54
IQ - Iraq 48
RO - Romania 45
KE - Kenya 37
ZA - Sudafrica 36
AU - Australia 28
ID - Indonesia 26
PK - Pakistan 26
CH - Svizzera 25
CL - Cile 24
CO - Colombia 24
SA - Arabia Saudita 21
LT - Lituania 20
IR - Iran 18
EC - Ecuador 17
TG - Togo 16
VE - Venezuela 15
JM - Giamaica 14
MA - Marocco 14
AL - Albania 13
PH - Filippine 13
PE - Perù 12
HN - Honduras 11
PY - Paraguay 11
CR - Costa Rica 10
GR - Grecia 10
JO - Giordania 10
NP - Nepal 10
AE - Emirati Arabi Uniti 9
EE - Estonia 9
HU - Ungheria 9
NZ - Nuova Zelanda 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
DK - Danimarca 8
IL - Israele 8
DZ - Algeria 7
PT - Portogallo 7
BG - Bulgaria 6
EG - Egitto 6
ET - Etiopia 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LA - Repubblica Popolare Democratica del Laos 6
MY - Malesia 6
AM - Armenia 5
BO - Bolivia 5
HR - Croazia 5
LU - Lussemburgo 5
LV - Lettonia 5
MD - Moldavia 5
OM - Oman 5
RS - Serbia 5
SM - San Marino 5
TN - Tunisia 5
TW - Taiwan 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
LB - Libano 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IS - Islanda 3
KW - Kuwait 3
NO - Norvegia 3
PA - Panama 3
PR - Porto Rico 3
AO - Angola 2
Totale 69.859
Città #
Amsterdam 9.481
Southend 5.676
Dallas 4.204
Woodbridge 3.099
Ann Arbor 2.233
Jacksonville 2.214
Houston 2.138
Ashburn 2.016
Chandler 1.869
Fairfield 1.852
San Jose 1.494
Singapore 1.466
Nanjing 1.223
Cambridge 895
Izmir 876
Wilmington 827
Beijing 755
Seattle 718
Boardman 542
Dublin 539
Nanchang 465
Council Bluffs 405
Helsinki 381
San Mateo 345
Princeton 318
New York 312
Lauterbourg 282
Düsseldorf 255
Hebei 249
Shenyang 242
Los Angeles 232
Tianjin 220
Changsha 200
Jiaxing 186
Santa Clara 169
Kunming 162
Moscow 158
Istanbul 147
Munich 136
Des Moines 134
Velikiy Novgorod 125
Ho Chi Minh City 119
Brussels 112
Shanghai 111
Toronto 96
Mülheim 93
Hanoi 92
Milan 91
Buffalo 87
San Diego 87
San Francisco 86
Urbino 83
Bremen 81
Jinan 79
Hangzhou 78
Orem 74
Guangzhou 73
Hong Kong 70
London 70
Frankfurt am Main 68
Orciano Di Pesaro 61
Lanzhou 59
Zhengzhou 58
Changchun 57
Venice 57
Dong Ket 54
Ningbo 53
Tokyo 53
Montreal 52
Nuremberg 52
Stockholm 52
Warsaw 52
São Paulo 50
Chicago 49
Rome 49
Menlo Park 48
Seongnam 45
Brooklyn 43
Vienna 42
Dearborn 41
Kraków 40
Atlanta 39
Denver 39
Norwalk 38
Turku 38
Haikou 36
Chennai 34
Shenzhen 34
Phoenix 31
Secaucus 28
Johannesburg 27
Taizhou 27
Auburn Hills 26
Manchester 26
The Dalles 26
Wuppertal 26
Augusta 24
Nairobi 24
Rio de Janeiro 24
Boston 23
Totale 52.527
Nome #
1-(2-Alkylamidoethyl)-6-methoxyindole Derivatives: A New Class of Potent Indole Melatonin Analogues. 3.197
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.191
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 3.154
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 3.153
SULLA MICELIANAMMIDE 2.113
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 879
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 875
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 435
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 359
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 312
Divergent synthesis of novel 9-deazaxanthine derivatives via late-stage cross-coupling reactions 293
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 293
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 292
ORGANIC REACTIONS OF FLUOROXY COMPOUNDS: ADDITION REACTIONS OF UNACTIVATED AND DEACTIVATED UNSATURATED LINKAGES OF STEROIDS 291
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 287
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 287
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 287
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 283
A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties 279
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 278
2-n-Butyl- 9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine and Analogues as A2A Adenosine Receptor Antagonists. Design, Synthesis, and Pharmacological Characterization 278
Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands 278
Synthesis and Biological Activity of new melatonin dimeric derivatives. 274
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 273
ENOLATES OF 17,20:20,21-BISMETHYLENEDIOXYPREDNISONE 271
An improved route to cycloalka[b]pyrrole 2-carboxylates 271
Alkyl 2 (Diphenyl-methyleneamino) acrylates in the Synthesis of α-Amino Acids 270
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 270
Synthesis of benzo[1,2-d;3,4-d’]diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists 269
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 268
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 259
Synthesis and Biological Evaluation of Metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), A Potent Antagonist of the A2AAdenosine Receptor for the Treatment of Parkinson’s Disease 258
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 256
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 256
5-(2-Ethyl-phenyl)-3-(3-methoxy-phenyl)-1H-[1,2,4]triazole (DL-111-IT ) and related compounds induce morphological apoptotic patterns in cultures of human tumor cell lines 255
Reassessing the melatonin pharmacophore: enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue. 254
"Hot spots" in Medicinal Chemistry 250
2,4,5-TRISUBSTITUTED OXAZOLES 248
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 247
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 246
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 243
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 239
POSITIVE ION-MASS SPECTRA AND COLLISION-INDUCED DISSOCIATION OF SOME 2,3-DIDEHYDRO AMINO ACIDS 237
N (Diphenylmethylene)-α,β−didehydroamino Acid Esters. Thermal and Lewis Acid Induced Dimerizations 237
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 235
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 235
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 235
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 232
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 228
2,4-Dicarboxy-pyrroles as Selective Non-Competitive mGluR1 Antagonists: an exploration of the role of the pyrrolic scaffold 226
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 226
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 226
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 225
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 223
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 222
An endocannabinoid mechanism for stress-induced analgesia 222
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 222
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 220
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 220
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 219
X-RAY STRUCTURE DETERMINATION OF MEXIPROSTIL, A NEW GASTROPROTECTIVE 16-METHOXY-16METHYL-PGE1 ANALOGUE 218
2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as Selective Glycine Antagonist with in vivo Activity. 218
N-(DIPHENYLMETHYLENE)-ALPHA,BETA-DIDEHYDROAMINO ACID ESTERS. THERMAL AND LEWIS ACID INDUCED DIMERIZATIONS 217
Peripherally Restricted FAAH Inhibitors 217
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 217
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 216
Conformationally Restrained Melatonin Analogs: Synthesis, Binding Affinity for the Melatonin Receptor, Evaluation of the Biological Activity, and Molecular Modeling Study 216
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 215
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 215
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 215
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 214
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 214
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 213
2-N-Acylaminoalkylindoles: Design and Quantitative Structure-Activity Relationship Studies Leading to MT2-Selective Antagonists. 211
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 211
(2-AMINOETHYL)IMIDAZOLES.SYNTHESIS OF 1,4-DIMETHYL-5-PHENYL-2-[2-(4-PHENYLPIPERAZINYL)ETHYL]IMIDAZOLE 210
Synthesis of (E)-8-(3-Chlorostyryl)caffeine Analogues Leading to 9-Deazaxanthine Derivatives as Dual A2AAntagonists/MAO-B Inhibitors 210
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 208
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 206
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 206
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 206
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 206
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 205
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 204
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 201
GENERALISED ELECTROPHILIC FLUORINATION BY FLUOROXY COMPOUNDS 201
2-(1,1'-BIPHEN-4-YL)-1,2,4-TRIAZOLE[5,1-a]ISOQUINOLINE (L-14105), A POTENTIAL ORALLY ACTIVE CONTRAGESTATIONAL AGENT FOR THE BITCH: STUDIES IN THE RAT, HAMSTER AND DOG 197
SUITABILITY OF FAST-ION BOMBARDMENT MASS SPECTROMETRY FOR THE INVESTIGATION OF 11,4-DIHYDROPYRIDINE DERIVATIVES 197
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 197
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 197
Pharmacological characterization of hydrolysis resistano analogs of oleoylethanolamide with potent anorexiant properties 195
UNIVERSITY EDUCATION OF MEDICINAL CHEMISTS: COMPARISON OF EIGHT COUNTRIES 195
ANGIOTENSIN CONVERTING ENZYME INHIBITORS AS ANTIHYPERTENSIVE AGENTS: 1-[´2-MERCAPTOCYCLOALKYL`CARBONYL]-L-PROLINES 195
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 195
Metastable ion studies in the characterization melatonin isomers 194
Modulation of anxiety through blockade of anandamide hydrolysis 194
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 193
SYNTHESIS AND BIOLOGICAL PROPERTIES OF N63-CARBOXAMIDES OF TEICOPLANIN ANTIBIOTICS. STRUCTURE-ACTIVITY RELATIONSHIPS. 193
2-n-butyl-9-methyl-8-(1,2,3)triazol-2yl-9H-purin-6-yl-amine (ST 1535) and analogs as A2a Adenosine receptor antagonists. Design, synthesis and pharmacological characterization 191
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 191
Totale 38.575
Categoria #
all - tutte 205.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.047 0 375 398 514 74 84 111 202 219 136 41 893
2022/20235.271 613 291 153 643 460 1.157 15 428 868 137 354 152
2023/20241.271 165 132 78 157 81 294 65 80 19 88 22 90
2024/20254.519 285 248 1.123 275 98 424 452 305 369 254 376 310
2025/202623.048 769 2.014 3.712 1.659 789 808 1.428 354 10.008 673 608 226
2026/20271.149 999 150 0 0 0 0 0 0 0 0 0 0
Totale 70.191